TPC
DAWN

Takeda Pharmaceutical Company’s Day One Biopharmaceuticals DAWN Stock Holding History

Takeda Pharmaceutical Company’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,840
Closed -$1.42M – 15
2024
Q1 		$1.42M Buy
+85,840
New +$1.28M 0.49% 10

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Takeda Pharmaceutical Company's DAWN Position: Q2 2024 in Review

Takeda Pharmaceutical Company sold out of Day One Biopharmaceuticals (DAWN) in Q2 2024, closing a stake of 85,840 shares — an estimated $1.42M sold.

Takeda Pharmaceutical Company first reported a position in DAWN in Q1 2024 and held it in 1 quarter. The position peaked at $1.42M in Q1 2024. 156 funds tracked by Wall St. Rank hold DAWN as of Q2 2024.

  • Takeda Pharmaceutical Company reported no remaining Day One Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Takeda Pharmaceutical Company sold 85,840 Day One Biopharmaceuticals shares in Q2 2024, an estimated $1.42M.
  • Takeda Pharmaceutical Company first reported a position in Day One Biopharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Takeda Pharmaceutical Company's Day One Biopharmaceuticals position peaked at $1.42M in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2024.

Based on Takeda Pharmaceutical Company's 13F filing for Q2 2024, filed 13 Feb 2025.